EAGLE THERAPEUTICS Trademark

Trademark Overview

On Tuesday, December 6, 2022, a trademark application was filed for EAGLE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EAGLE THERAPEUTICS trademark a serial number of 97706207. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, July 10, 2024. This trademark is owned by SPEID & ASSOCIATES INC.. The EAGLE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
eagle therapeutics

General Information

Serial Number97706207
Word MarkEAGLE THERAPEUTICS
Filing DateTuesday, December 6, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 5, 2023
Primary Code042
First Use Anywhere DateFriday, March 18, 2022
First Use In Commerce DateFriday, March 18, 2022

Trademark Owner History

Party NameSPEID & ASSOCIATES INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Addresssan diego, CA 92130

Trademark Events

Event DateEvent Description
Friday, December 9, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Tuesday, September 19, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 19, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 27, 2023FINAL REFUSAL WRITTEN
Wednesday, December 27, 2023FINAL REFUSAL E-MAILED
Wednesday, December 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 10, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 10, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 20, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, March 20, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

therapeutics eagle development research pharmaceutical